AVIR Atea Pharmaceuticals, Inc.
$4.25▲ +1.80%
Healthcare
Other
Volume 137.6K
Avg Volume (10D) 328.4K
Key Metrics & Fundamentals
Market Cap
$340.47M
P/E Ratio
–
Div Yield
0.00%
52W Range
2.87 - 6.45
% vs 50 MA
-18.46%
% vs 200 MA
-15.22%
RSI-14
30.7
MACD Histogram
-0.0600
Beta (1Y vs SPY)
0.79
Free Cash Flow
-$37.08M
Gross Rev
$0
Gross Profit
$0
EBITDA
-$35.00M
COGS
–
Operating Exp
$35.10M
Operating Income
-$35.10M
EBIT
-$35.10M
Pretax Income
-$32.91M
Net Income
-$32.93M
EPS (Diluted)
-0.41
Price & Volume History
Loading chart…
Recent News
Atea Pharmaceuticals to Present at the Morgan Stanley 24th Annual Global Healthcare Conference
GlobeNewswire · Sep 8, 2026 7:00 AM ET
Atea (AVIR) Q2 2026 Earnings Call Transcript
Motley Fool · Aug 19, 2026 5:13 PM ET
Atea Pharmaceuticals, Inc. Q2 2026 Earnings Call Summary
Moby · Aug 12, 2026 8:55 PM ET
Atea Pharmaceuticals Q2 Earnings Call Highlights
MarketBeat · Aug 12, 2026 6:04 PM ET
Atea Pharmaceuticals Reports Second Quarter 2026 Financial Results and Provides Business Update
GlobeNewswire · Aug 12, 2026 4:05 PM ET
Atea Pharmaceuticals to Host Second Quarter 2026 Financial Results and Business Update Conference Call on August 12, 2026
GlobeNewswire · Aug 5, 2026 7:00 AM ET
Financial Overview - Income Statement
Quarterly
No financial data available. Click Refresh on the ticker to load latest fundamentals.
See AVIR's money flow as a full page
Social Sentiment
Loading Reddit posts…
AI Analysis
Click Generate Analysis for an AI-powered summary, bull & bear case, and recent performance review.
Not financial advice.
All data, scores, charts, and analysis on this site are provided for informational and educational
purposes only and do not constitute financial, investment, legal, or tax advice.
Past performance is not indicative of future results.
See our Legal Notice for full details.